Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

SELARL PHARMACIE DES TILLEULS : revenue, balance sheet and financial ratios

SELARL PHARMACIE DES TILLEULS is a French company founded 11 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in VILLETANEUSE (93430), this company of category PME shows in 2015 a revenue of 1.4 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SELARL PHARMACIE DES TILLEULS (SIREN 809275464)
Indicator 2018 2017 2016 2015
Revenue N/C N/C N/C 1 404 503 €
Net income 209 960 € 143 100 € 123 843 € 76 789 €
EBITDA N/C N/C N/C 118 705 €
Net margin N/C N/C N/C 5.5%

Revenue and income statement

In 2018, SELARL PHARMACIE DES TILLEULS generates positive net income of 210 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2015-2018: 77 k€ -> 210 k€.

Net income (2018) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

209 960 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 175%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 32%. The balance between equity and debt is satisfactory.

Debt ratio (2018) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

174.931%

Financial autonomy (2018) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

32.371%

Asset age ratio (2018) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

69.9%

Solvency indicators evolution
SELARL PHARMACIE DES TILLEULS

Sector positioning

Debt ratio
174.93 2018
2016
2017
2018
Q1: 40.91
Med: 114.61
Q3: 266.0
Average -15 pts over 3 years

In 2018, the debt ratio of SELARL PHARMACIE DES TILL... (174.93) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
32.37% 2018
2016
2017
2018
Q1: 21.63%
Med: 38.41%
Q3: 58.07%
Average +16 pts over 3 years

In 2018, the financial autonomy of SELARL PHARMACIE DES TILL... (32.4%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 333.19. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2018) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

333.19

Liquidity indicators evolution
SELARL PHARMACIE DES TILLEULS

Sector positioning

Liquidity ratio
333.19 2018
2016
2017
2018
Q1: 118.21
Med: 162.86
Q3: 228.31
Excellent

In 2018, the liquidity ratio of SELARL PHARMACIE DES TILL... (333.19) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2018) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2018) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2018) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2018) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
SELARL PHARMACIE DES TILLEULS

Positioning of SELARL PHARMACIE DES TILLEULS in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 177 transactions of similar company sales in 2018, the value of SELARL PHARMACIE DES TILLEULS is estimated at 2 643 584 € (range 1 970 292€ - 4 348 078€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2018
177 transactions
1970k€ 2643k€ 4348k€
2 643 584 € Range: 1 970 292€ - 4 348 078€
NAF 5 année 2018

Valuation method used

Net Income Multiple
209 960 € × 12.6x = 2 643 584 €
Range: 1 970 293€ - 4 348 078€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 177 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare SELARL PHARMACIE DES TILLEULS with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about SELARL PHARMACIE DES TILLEULS

What is the revenue of SELARL PHARMACIE DES TILLEULS ?

The revenue of SELARL PHARMACIE DES TILLEULS in 2015 is 1.4 M€.

Is SELARL PHARMACIE DES TILLEULS profitable?

Yes, SELARL PHARMACIE DES TILLEULS generated a net profit of 210 k€ in 2018.

Where is the headquarters of SELARL PHARMACIE DES TILLEULS ?

The headquarters of SELARL PHARMACIE DES TILLEULS is located in VILLETANEUSE (93430), in the department Seine-Saint-Denis.

Where to find the tax return of SELARL PHARMACIE DES TILLEULS ?

The tax return of SELARL PHARMACIE DES TILLEULS is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SELARL PHARMACIE DES TILLEULS operate?

SELARL PHARMACIE DES TILLEULS operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.